Written by epgonline.org - Last updated 01 November 2018

A retrospective look at news and developments from the field of IBD for UEG Week 2018 | October 2018 | Vienna, Austria

Scroll down for our daily reports, collated for your reference below 

United European Gastroenterology represents over 30,000 European specialists across all fields concerned with digestive and liver disease. The annual Congress UEG Week is one of the leading gastroenterology meetings of the year drawing participants from around the world to share their research and discover the latest developments from their peers. In 2018, UEG Week returned to the vibrant city of Vienna and with around 4,000 abstracts submitted, a lively discussion was guaranteed across a range of GI-related topics. Although a variety of topics were covered as part of UEG Week, we chose to focus on IBD given the range of exciting developments with the potential to change the lives of patients with Crohn’s disease and ulcerative colitis. Here, we take a look at highlights from some of the most interesting presentations and posters.

Insight from UEGW2018

Stephen Smith

UEGW 2018 | Day 5 Highlights

Posted 17 days ago

A number of presentations and abstracts shared updates on the latest developments for new treatments and therapies, some of which are pioneering new modes of action. Here we look to the horizon, gaining insights into the latest data for novel treatments targeting Janus kinase (JAK) signalling, MAdCAM-1-mediated adhesion and the interleukin IL-23.


Stephen Smith

UEGW 2018 | Day 4 Highlights

Posted 18 days ago

While clinical trials have demonstrated the efficacy of new biologics used in ulcerative colitis and/or Crohn’s disease, it is apparent that patients enrolled into clinical trials are not representative of the general patient population. Real-world evidence offers the chance to fill this gap and provide insights into how these treatments perform in everyday clinical practice. In today’s article we review some of the real-world data shared at UEG Week on vedolizumab and ustekinumab, as well as comparison of the originator and biosimilar versions of infliximab.

Stephen Smith

UEGW 2018 | Day 3 Highlights

Posted 19 days ago

The introduction of biologic therapies in the last 20 years has revolutionised the management of IBD. However, questions remain over the best approach to its management, such as when to introduce, switch and de-escalate biologics. Several posters and presentations addressed these topics at UEG Week 2018; here is a selection of some of the highlights.

Stephen Smith

UEGW 2018 | Day 2 Highlights

Posted 20 days ago

In this article, we provide an overview of some of the presentations and posters at UEG Week 2018 that studied the course of IBD and investigated the associated risk of cancer.

Stephen Smith

UEGW 2018 | Day 1 Highlights

Posted 21 days ago

A series of presentations and posters at UEG Week 2018 explored resource utilisation, the costs associated with IBD management and whether we can predict who may need additional resources...



This content has been developed independently of the sponsors, Sandoz, who have had no editorial input into the content.

Top content picks for you

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Inflammatory Bowel Disease Knowledge Centre

Inflammatory Bowel Disease Knowledge Centre

The Inflammatory Bowel Disease (IBD) Knowledge Centre contains key information relating to the epidemiology and pathophysiology of Crohn’s disease and ulcerative colitis, highlighting prevalence, impact and unmet needs and the underlying inflammatory processes that drive IBD, considering some of the key inflammatory pathways.